SecBot SecBot
144 ·Filed Aug 10, 2026

DNTH

Dianthus Therapeutics, Inc. /DE/
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001974158-26-000096
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small and conducted under a pre-arranged 10b5-1 plan, so it carries no negative signal. Monitor the actual sale on Form 4 for completion, but no trading action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$108.49
T+0 close · Aug 10, 2026 · via day close
Latest settled
−20.91%
T+60 · $85.81
Vs SPY
−20.42%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 11 $108.49entry
  2. T+1 · 3mo ago +3.61%α +3.36% · $112.41
  3. T+5 · 3mo ago +6.50%α +6.90% · $115.54
  4. T+20 · 2mo ago −1.34%α −0.28% · $107.04
  5. T+60 · 13d ago −20.91%α −20.42% · $85.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Simon Read, an officer of Dianthus Therapeutics, filed a Form 144 to sell 5,550 shares of common stock valued at approximately $624,375, with the sale to be executed through a 10b5-1 plan adopted on May 8, 2026. The filing is a routine advance notice of an intended sale under a pre-arranged trading plan and does not indicate a change in the insider's view of the company's prospects. Given the small size of the proposed sale relative to the company's $6.1B market cap, the filing is neutral and low-impact.

Key Facts

  • Officer Simon Read filed a Form 144 to sell 5,550 shares of common stock.
  • The estimated aggregate market value of the proposed sale is $624,375.
  • The sale is to be made pursuant to a 10b5-1 selling plan dated May 8, 2026.
  • The proposed sale represents a very small fraction of the company's $6.1B market capitalization.
  • The filing is an advance notice of intent to sell, not a completed transaction.

Financial Impact

Proposed sale of 5,550 shares valued at $624,375, representing ~0.01% of market cap.

dilution

Risk Factors

  • Insider selling could be misinterpreted by the market as a negative signal despite the 10b5-1 plan.
  • The actual sale may not occur, but the filing indicates the insider at least considered selling.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001974158-26-000096
Document: 0001974158-26-000096-index.html0001974158-26-000096
Document: 0001974158-26-000096.txt0001974158-26-000096

Track record

23 reports on DNTH

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
  2. Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
  5. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  6. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  7. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
  8. Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  9. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (10h 32m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 10, 2026